Khosla Ventures leads $6m round for Fountain Therapeutics
San Francisco-based Fountain Therapeutics , a biopharmaceutical company focused on treating age-related diseases, has secured $6 million in Series A-1 financing.
San Francisco-based Fountain Therapeutics , a biopharmaceutical company focused on treating age-related diseases, has secured $6 million in Series A-1 financing.
Copyright PEI Media
Not for publication, email or dissemination